top of page
MEMBERS
SooBeen Heo, B.S.
FORMER LAB MEMBER
AFFILIATION
-
DEPARTMENT
-
EDUCATION
-
CONTACT
-
PUBLICATIONS
• Kong SY, Baek JY, Shim HE, Heo SB, Sun JY, Choi MG, Park SC, Hong CW, Kim SH, Park SY. Clinical utility of monitoring circulating tumor DNA using a targeted next-generation sequencing panel in patients with colorectal cancer. Annals of Laboratory Medicine. 2025;45(4):450-458. (IF: 3.9)
• Kim T, Lu T, Kim T, Heo SB, Jung SY, Kong SY, Park BS, Jeon H, Kim J, Kim D, Lee SK. Combinatorial CRISPR screen reveals FYN and KDM4 as targets for synergistic drug combination for treating triple negative breast cancer. eLife. 2025;13:RP93921-.
• Woo SM, Kong SY, Jeon JW, Lee DE, Han NY, Heo SB, Kim HJ, Lee MR, Park HM, Han SS, Park SJ, Kim TH, Lee WJ, Kim YH. Mutant KRAS and GATA6 stratify survival in patients treated with chemotherapy for pancreatic adenocarcinoma: a prospective cohort study. Cancers. 2025;17(5):896-. (IF: 4.4)
AWARDS
• Outstanding Oral Presentation Award, Korean Society for Genetic Diagnostics (KSGD), Jun 2023
PRESENTATIONS
• Monitoring of circulating tumor DNA as a biomarker in colorectal cancer. Poster presented at: 2023 AACR-KCA Joint Conference on Precision Medicine in Cancer; Nov 16, 2023; Seoul, Korea.
• Genetic alterations of circulating tumor DNA in advanced pancreatic cancer patients receiving 5-fluorouracil based chemotherapy. Oral presentation at: 18th Annual Meeting of the Korean Society for Genetic Diagnostics (KSGD); Jun 1, 2023; Seoul, Korea.
• Dynamics of genomic instability of circulating tumor DNA in pancreatic cancer patients. Poster presented at: International Pancreatobiliary Meeting (IPBM) 2023; Apr 21–22, 2023; Incheon, Korea.
• Dynamics of genomic instability of circulating tumor DNA in pancreatic cancer patients. Poster presented at: American Association for Cancer Research (AACR) Annual Meeting 2023; Apr 13–19, 2023; Orlando, FL, USA.
• Genetic alterations of circulating tumor DNA in advanced pancreatic cancer patients receiving 5-fluorouracil based chemotherapy. Poster presented at: American Association for Cancer Research (AACR) Annual Meeting 2023; Apr 13–19, 2023; Orlando, FL, USA.
• Genetic alterations in circulating tumor DNA in pancreatic cancer patients treated by 5-FU based chemotherapy. Oral presentation at: LMCE KSLM 2022 & 63rd Annual Meeting; Oct 28, 2022; Seoul, Korea.
bottom of page